調查批次:CHT2014-04 | 檢體寄出日期:2014-04-21 | 報告回收截止日期:2014-04-28 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
1 |
3 |
1.4 |
0.2 |
16.7 |
1.0 |
-1.0 |
33 |
3.7 |
0.2 |
5.7 |
0.7 |
0.0 |
24 |
RH07b | RH07 | 2 |
1 |
3 |
1.5 |
0.3 |
25.0 |
1.5 |
0.0 |
50 |
3.6 |
0.1 |
2.9 |
0.4 |
-0.5 |
12 |
RH14 | RH14 | 4 |
1 |
3 |
1.5 |
0.3 |
25.0 |
1.5 |
0.0 |
50 |
3.9 |
0.4 |
11.4 |
1.4 |
1.1 |
48 |
RH15 | RH15 | 2 |
1 |
3 |
1.6 |
0.4 |
33.3 |
2.0 |
1.0 |
67 |
3.9 |
0.4 |
11.4 |
1.4 |
1.1 |
48 |
CL009 | CL009 | 3 |
1 |
3 |
1.5 |
0.3 |
25.0 |
1.5 |
0.0 |
50 |
3.7 |
0.2 |
5.7 |
0.7 |
0.0 |
24 |
CL010 | CL010 | 1 |
1 |
3 |
1.6 |
0.4 |
33.3 |
2.0 |
1.0 |
67 |
3.4 |
-0.1 |
-2.9 |
-0.4 |
-1.6 |
-12 |
CL012 | CL012 | 7 |
1 |
3 |
1.5 |
0.3 |
25.0 |
1.5 |
0.0 |
50 |
3.7 |
0.2 |
5.7 |
0.7 |
0.0 |
24 |
CL013 | CL013 | 3 |
1 |
5 |
1.1 |
-0.1 |
-8.3 |
-0.5 |
-4.0 |
-17 |
3.5 |
0.0 |
0.0 |
0.0 |
-1.1 |
0 |
CL014a | CL014 | 3 |
1 |
3 |
1.6 |
0.4 |
33.3 |
2.0 |
1.0 |
67 |
3.8 |
0.3 |
8.6 |
1.1 |
0.5 |
36 |
CL015 | CL015 | 2 |
1 |
3 |
1.4 |
0.2 |
16.7 |
1.0 |
-1.0 |
33 |
3.5 |
0.0 |
0.0 |
0.0 |
-1.1 |
0 |
Median of RIA Group |
1.5 |
3.7 |
||||||||||||||
Range of RIA Group |
1.1 - 1.6 |
3.4 - 3.9 |
||||||||||||||
Robust mean of RIA Group |
1.5 ( n = 10 ) |
3.7 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
0.10 |
0.19 |
||||||||||||||
CV of RIA Group |
6.7% |
5.1% |
||||||||||||||
Median of European RIA Labs |
1.2 ( n = 103 ) |
3.5 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.0 - 1.5 |
3.1 - 4.0 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
3 |
9 |
1.1 |
-0.1 |
-8.3 |
-0.5 |
0.0 |
-17 |
3.5 |
0.0 |
0.0 |
0.0 |
0.6 |
0 |
RH02c | RH02 | 2 |
3 |
1 |
1.0 |
-0.2 |
-16.7 |
-1.0 |
-0.8 |
-33 |
3.2 |
-0.3 |
-8.6 |
-1.1 |
-0.3 |
-36 |
RH06 | RH06 | 1 |
3 |
9 |
1.0 |
-0.2 |
-16.7 |
-1.0 |
-0.8 |
-33 |
3.1 |
-0.4 |
-11.4 |
-1.4 |
-0.6 |
-48 |
RH07a | RH07 | 1 |
3 |
2 |
0.9 |
-0.3 |
-25.0 |
-1.5 |
-1.5 |
-50 |
2.7 |
-0.8 |
-22.9 |
-2.9 |
-1.9 |
-95 |
RH12 | RH12 | 2 |
3 |
2 |
1.1 |
-0.1 |
-8.3 |
-0.5 |
0.0 |
-17 |
3.4 |
-0.1 |
-2.9 |
-0.4 |
0.3 |
-12 |
RH19 | RH19 | 1 |
3 |
2 |
1.2 |
0.0 |
0.0 |
0.0 |
0.8 |
0 |
3.6 |
0.1 |
2.9 |
0.4 |
1.0 |
12 |
RH20 | RH20 | 4 |
3 |
7 |
1.1 |
-0.1 |
-8.3 |
-0.5 |
0.0 |
-17 |
3.0 |
-0.5 |
-14.3 |
-1.8 |
-1.0 |
-60 |
CL005 | CL005 | 1 |
3 |
9 |
1.0 |
-0.2 |
-16.7 |
-1.0 |
-0.8 |
-33 |
3.2 |
-0.3 |
-8.6 |
-1.1 |
-0.3 |
-36 |
CL006a | CL006 | 1 |
3 |
7 |
1.1 |
-0.1 |
-8.3 |
-0.5 |
0.0 |
-17 |
3.0 |
-0.5 |
-14.3 |
-1.8 |
-1.0 |
-60 |
CL008 | CL008 | 3 |
3 |
2 |
0.9 |
-0.3 |
-25.0 |
-1.5 |
-1.5 |
-50 |
3.5 |
0.0 |
0.0 |
0.0 |
0.6 |
0 |
CL011 | CL011 | 1 |
3 |
13 |
1.3 |
0.1 |
8.3 |
0.5 |
1.5 |
17 |
3.6 |
0.1 |
2.9 |
0.4 |
1.0 |
12 |
Median of CLIA Group |
1.1 |
3.2 |
||||||||||||||
Range of CLIA Group |
0.9 - 1.3 |
2.7 - 3.6 |
||||||||||||||
Robust mean of CLIA Group |
1.1 ( n = 11 ) |
3.3 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
0.13 |
0.31 |
||||||||||||||
CV of CLIA Group |
11.8% |
9.4% |
||||||||||||||
Median of European CLIA Labs |
1.2 ( n = 1183 ) |
3.5 ( n = 1156 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.0 - 1.3 |
3.1 - 3.7 |
||||||||||||||
Median of All Labs |
1.2 |
3.5 |
||||||||||||||
Range of All Labs |
0.9 - 1.6 |
2.7 - 3.9 |
||||||||||||||
Robust mean of All Labs |
1.3 ( n = 21 ) |
3.5 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.28 |
0.33 |
||||||||||||||
CV of All Labs |
21.5% |
9.4%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.2 |
3.5 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.0 - 1.3 |
3.1 - 3.7 |
||||||||||||||
Mean of All European Labs |
1.2 ( n = 1403 ) |
3.4 ( n = 1373 ) |
||||||||||||||
SD of All European Labs |
0.17 |
0.39 |
||||||||||||||
CV of All European Labs |
14.8% |
11.4% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.20 |
0.28 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-04-29